Get The Daily Rip

Stocktwits Top 25 – Week 19 📉

Good evening, everyone. Welcome to the Stocktwits Top 25 Newsletter for Week 19 of 2022.

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD), and tracks their performances over time. 

Here are the Stocktwits Top 25 Lists for Week 19:

S&P 500

ST Top 25 S&P 500

The S&P 500 Top 25 list felt pretty familiar this week — that’s because all but one stock still sat inside the Top 25.

Diamondback Energy fell out of the list after dipping -6.65% this week. 

It was replaced by Lockheed Martin, which found its way into the list in the simplest of ways: losing less than others. It only fell -3.17% this week, winning the war of attrition against Diamondback.

Outside of this swapping of positions, it was business as usual. The biggest winner on the list this week was CF Industries, which moved up eight spots after posting a +4.05% gain on the week.

The only other gainer was Baker Hughes Company, which rose +6.16% and gained five positions on the list.

Members of the Top 25 list were down more aggressively than the index — they lost -3.08% as the S&P 500 fell -1.41% this week. Check out how the momentum meter has looked against the actual index so far this year:


The Large-Cap Nasdaq 100

Despite weakness from the Nasdaq 100’s Top 25 leader this week, the index managed to pull out a positive momentum reading — and many names moved north in spite of challenging market conditions.

The list’s worst performance came from its leader, Constellation Energy, which posted a -9.39% loss on the week. It reprised its leader position thanks to a healthy buffer between it and runner-up Kraft Heinz.

Constellation also appears on the more-competitive S&P Top 25 list. It fell from #15 to #20 on the list this week.

On the other hand, the list’s most impressive performance came courtesy of Electronic Arts it bursted onto the list from #37 on the list last week by making an +8.37% gain in the week.

It was joined by two other newcomers: NetEase Inc (+4.58%) and O’Reilly Automotive (+4.47%)

The names replaced Paychex, Cintas, and Booking Holdings, which all fell off the list this week.

The Top 25’s momentum meter was down -0.59% this week, which was still better than the -1.33% drop in the index. This implies the top stocks in the index did better than the broader index.


The Growth-Centric Russell 2000

There was plenty of action on the the R2K Top 25 list this week. Unfortunately, very little of it was good.

The list’s top performer was Veru Inc, which managed a +53.66% gain in the week. It went all the way from #59 last week to #4 this week. Just goes to show you — anything could happen!

It was joined by one other big gainer: Evolus Inc., which added +19.82% this week. It sat just outside the Top 25 list this time last week (at #29.)

The list’s other two sole gainers were Scorpio Tankers and Highpeak Energy. Every other member of the list was a loser…

And, as that implies, there were plenty of big losers: Target Hospitality was the biggest loser of them all, down -17.97% this week. It lost 14 positions and was at risk of falling off the list.

A number of oil and energy plays got hammered this week with double-digit losses, too: among them were the Top 25 list’s leader, Nextier Oilfield Solutions (-10.26%). It was joined by Antero Resources (-12.73%) and Consol Energy (-10.77%).

Three names fell off the list — they all had double-digit losses. Check them out below.

The Russell’s Top 25 companies outperformed the broader index, lending some fire to momentum traders. The R2K’s Momentum Meter came in down -1.93% this week, while the broader index was down -2.23% this week.



The Top 25 list’s Top Dawg was Veru Inc. (That was hardly a surprise.)

The company rose more than +53% from Friday to Friday, besting every other constituent of the lists by a healthy margin.

Those moves were made possible thanks to a an upgrade from Jefferies, which raised its price target after citing “a favorable response from the FDA.”

It was a huge boost to the company, which is pursuing authorization for a COVID-19 therapy called sabizabulin.

Here’s a glimpse of the chart YTD:

$VERU is up 109% YTD.

See Y’all Next Week 🤙